Trending:
Lonza and GE Healthcare are developing a new biologics facility in Guangzhou, China.
Virginia Cancer Specialists (VCS) opened a phase I clinical research facility in Fairfax, Northern Virginia,...
Read More...
Leading global contract development and manufacturing organisation (CDMO) Vetter began construction of its new production...
Read More...
Massachusetts-based biotechnology company Vertex Pharmaceuticals (Vertex) is currently relocating its headquarters from Cambridge to Fan...
Read More...
Alpha Biologics, a contract biomanufacturing service provider, commissioned a new cGMP biomanufacturing plant in April
Read More...
Vivalis opened a new R&D facility in Saint-Herblain, Nantes, France on 28 June 2010. The...
Read More...
The Van Andel Institute completed a $178m phase II expansion on its cancer research facility...
Read More...
Vetter Pharma's new small-scale fill-finish facility is in Skokie, a suburb of Chicago. Located at...
Read More...
Velesco Pharmaceutical is a provider of analytical procedure development, drug formulation, stability testing and consul
Read More...
Vetter is a leading contract development manufacturing organisation that specialises in the aseptic filling of...
Read More...
VaxGen opened a new biopharmaceutical manufacturing facility in South San Francisco, California, US in June...
Read More...
Go Top
